Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock
Cathie Wood's ARK ETFs published their daily trades for Friday, January 31st, 2025, with a notable emphasis on the biotech sector. Leading the charge in purchases was CRISPR Therapeutics AG ...
Le Lézard14h
Mammoth Biosciences Announces New Results on NanoCas ? the First Efficient Ultracompact Extrahepatic Gene Editor
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...
Pharmaceutical Technology16h
NHS England to offer Casgevy for sickle cell disease patients
The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...
Exchange Traded Concepts LLC Decreases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...